These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16404982)

  • 1. [Pre-clinical trials of new spore probiotics].
    Osipova IG; Sorokulova IB; Vasil'eva EA; Budanova EV
    Vestn Ross Akad Med Nauk; 2005; (12):36-40. PubMed ID: 16404982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study of the safety of probiotic bacilli].
    Sorokulova IB; Osipova IG; Tereshkina NV; Vasil'eva EA; Budanova EV
    Vestn Ross Akad Med Nauk; 2006; (1):50-4. PubMed ID: 16496957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative study of the biological properties of Biosporin and other commercial Bacillus-based preparations].
    Sorokulova IB
    Mikrobiol Z; 1997; 59(6):43-9. PubMed ID: 9511375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The highly effective biological preparation biosporin].
    Smyrnov VV; Reznyk SR; Sorokulova IV
    Lik Sprava; 1994; (5-6):133-8. PubMed ID: 7831880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of probiotics from bacilli on macrophage functional activity].
    Sorokulova IB
    Antibiot Khimioter; 1998; 43(2):20-3. PubMed ID: 9551169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Outlook for using bacteria of the genus Bacillus for the design of new biopreparations].
    Sorokulova IB
    Antibiot Khimioter; 1996; 41(10):13-5. PubMed ID: 9027285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety of bacteria of the genus Bacillus, forming the base of some probiotics].
    Osipova IG; Sorokulova IB; Tereshkina NV; Grigor'eva LV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (6):68-70. PubMed ID: 9949507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolation and study of perspective probiotic strain of spore-forming bacteria from Bacillus genus].
    Grin'ko OM; Zverev VV; Kaloshin AA; Mikhaĭlova NA; Arzumanian VG
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):85-9. PubMed ID: 19623717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of antibiotic preparations and their combinations with probiotics on the intestinal microflora of mice].
    Furzikova TM; Sorokulova IB; Serhiĭchuk MH; Sichkar SV; Smirnov VV
    Mikrobiol Z; 2000; 62(3):26-35. PubMed ID: 10932540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of two Bacillus probiotic strains for human use.
    Sorokulova IB; Pinchuk IV; Denayrolles M; Osipova IG; Huang JM; Cutting SM; Urdaci MC
    Dig Dis Sci; 2008 Apr; 53(4):954-63. PubMed ID: 17934835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative evaluation of probiotic activity in respect to in vitro pneumotropic bacteria and pharmacodynamics of biosporin-strain producers in patients with chronic obstructive pulmonary diseases].
    Bilev AE
    Voen Med Zh; 2002 Sep; 323(9):54-7. PubMed ID: 12449758
    [No Abstract]   [Full Text] [Related]  

  • 12. Technology for evaluating the ability of probiotic strains to accumulate copper ions
    Sizentsov A; Salnikova E; Sizentsov Y; Peshkov S; Barysheva E; Naumenko O; Romanenko N
    Vet World; 2021 Jul; 14(7):1752-1759. PubMed ID: 34475694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of Bacillus strains as potential probiotics and subsequent confirmation of the in vivo effectiveness of Bacillus subtilis MA139 in pigs.
    Guo X; Li D; Lu W; Piao X; Chen X
    Antonie Van Leeuwenhoek; 2006 Aug; 90(2):139-46. PubMed ID: 16820971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of the cultivation conditions on the properties of bacilli comprising the basis of probiotics].
    Furzikova TM; Sergeĭchuk MG; Sorokulova IB; Smirnov VV
    Mikrobiol Z; 1999; 61(5):19-27. PubMed ID: 10643273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity in the antibacterial potential of probiotic cultures Bacillus licheniformis MCC2514 and Bacillus licheniformis MCC2512.
    Shobharani P; Padmaja RJ; Halami PM
    Res Microbiol; 2015; 166(6):546-54. PubMed ID: 26100933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of adhesive properties of bacteria with promise for creation of complex probiotic preparations].
    Tsaruk'ianova IG; Smirnova EV
    Mikrobiol Z; 2005; 67(2):88-95. PubMed ID: 16018221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative assessment of survival of probiotic microorganisms from commercial preparations under the conditions in vitro].
    Darmov IV; Chicherin IIu; Erdiakov AS; Pogorel'skiĭ IP; Lundovskikh IA
    Eksp Klin Gastroenterol; 2011; (9):96-101. PubMed ID: 22629784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Properties of the isolated Bacillus subtilis strains and their influence on the intestinal microflora of experimental mice].
    Gataullin AG; Mikhaĭlova NA; Blinkova LP; Romanenko EE; Elkina SI; Gaĭderov AA; Kalina NG
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (2):91-4. PubMed ID: 15188573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Bacillus subtilis strains as probiotics and their potential as a food ingredient.
    Permpoonpattana P; Hong HA; Khaneja R; Cutting SM
    Benef Microbes; 2012 Jun; 3(2):127-35. PubMed ID: 22433662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibility to antimicrobial drugs of strains of bacilli used as a basis for various probiotics].
    Smirnov VV; Rudenko AV; Samgorodskaia NV; Sorokulova IB; Reznik SR; Sergeĭchuk TM
    Antibiot Khimioter; 1994 Apr; 39(4):23-8. PubMed ID: 7826169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.